Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 901,900 | 286,700 | 1,277,713 | 786,031 | 688,938 |
| Marketable Securities | 46,700 | 835,900 | 31,361 | 240,889 | 194,901 |
| Receivables | 13,100 | 6,400 | 100,041 | 90 | 50,410 |
| Inventories | 32,000 | 23,900 | 19,433 | 10,354 | 1,749 |
| TOTAL | $1,247,100 | $1,283,900 | $1,497,799 | $1,099,119 | $949,850 |
| Non-Current Assets | |||||
| PPE Net | 116,300 | 99,300 | 108,725 | 105,168 | 102,506 |
| Investments And Advances | 0 | 0 | 451 | 914 | 2,168 |
| Intangibles | 0 | 0 | 4,061 | 3,409 | 4,684 |
| Other Non-Current Assets | 370,300 | 287,000 | 237,573 | 122,353 | 60,257 |
| TOTAL | $486,600 | $386,300 | $350,810 | $231,844 | $169,615 |
| Total Assets | $1,733,700 | $1,670,200 | $1,848,609 | $1,330,963 | $1,119,465 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 319,100 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 278,400 | 204,800 | 152,962 | 217,002 | 130,601 |
| Other current liabilities | 12,300 | 47,400 | 53,078 | 67,451 | 88,204 |
| TOTAL | $636,400 | $277,700 | $216,418 | $297,788 | $229,204 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 281,328 | 260,932 | 120,462 |
| Other Non-Current Liabilities | 95,200 | 351,900 | 99,492 | 27,931 | 3,855 |
| TOTAL | $95,200 | $351,900 | $380,820 | $288,863 | $124,317 |
| Total Liabilities | $731,600 | $629,600 | $597,238 | $586,651 | $353,521 |
| Shareholders' Equity | |||||
| Common Shares | 100 | 100 | 36 | 33 | 31 |
| Retained earnings | 1,002,000 | 1,040,500 | 1,251,335 | 744,279 | 765,913 |
| TOTAL | $1,002,100 | $1,040,600 | $1,251,371 | $744,312 | $765,944 |
| Total Liabilities And Equity | $1,733,700 | $1,670,200 | $1,848,609 | $1,330,963 | $1,119,465 |